NATERA INC · held by 2 funds · data as of 2026-06-03
Sector
Healthcare
Industry
Diagnostics & Research
Market cap
$30.47B
Price
$211.79
12-mo
+29.30%
Held by
2 funds
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single…